ClinicalTrialsFinder

CRS - Cytokine Release Syndrome Clinical Trials in Tianjin

1 recruitingTianjin, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

MyelomaCRS - Cytokine Release Syndrome
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT07106671